Clinical Trials Browser

Colonic Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT03259867 2026-04-16

TATE-PD1

Phase 2 Recruiting

54 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Stomach Neoplasms, Disease Progression

NCT04692675 2026-03-27

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

Phase NA Recruiting

508 enrolled

Genitourinary

Prostatic Neoplasms, Disease Progression

NCT04678648 2026-03-18

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Phase 1 Recruiting

134 enrolled

CNSGastrointestinalThoracic

Colonic Neoplasms, Glioblastoma, Lung Neoplasms, Neoplasms, Pancreatic Neoplasms, Disease Progression

NCT07049055 2026-02-27

Carolyn-USA

Phase 1/2 Recruiting

144 enrolled

Gastrointestinal

Neoplasm Metastasis, Pancreatic Neoplasms, Disease Progression

NCT07281833 2026-02-27

CAPIcorn

Phase 3 Recruiting

250 enrolled

Breast

Breast Neoplasms, Neoplasm Metastasis, Disease Progression

NCT07369570 2026-02-24

REMRI

Phase NA Recruiting

100 enrolled

Genitourinary

Disease, Prostatic Neoplasms, Disease Progression

NCT06877949 2026-02-20

MONITOR-RCT

Phase NA Recruiting

420 enrolled

Breast

Breast Neoplasms, Disease Progression

NCT04954820 2026-02-05

ReLUTH

Phase 2 Recruiting

146 enrolled

EndocrineNET

Neuroendocrine Tumors, Disease Progression

Clinical Trials

Neratinib + Valproate in Advanced Solid Tumors, w/Expansion Cohort in Ras-Mutated Ca

TATE-PD1

Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer

A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies

Carolyn-USA

CAPIcorn

REMRI

MONITOR-RCT

ReLUTH